Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Iovance Biotherapeutics Inc. buy BiotechBee

Start price
€7.14
24.06.23 / 50%
Target price
€9.00
30.11.25
Performance (%)
73.39%
Price
€12.38
09.05.24
Summary
This prediction is currently active. With a performance of 73.39% the BUY prediction by BiotechBee is a big success. This prediction currently runs until 30.11.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Iovance Biotherapeutics Inc. 12.908% 12.908%
iShares Core DAX® 3.178% 0.980%
iShares Nasdaq 100 2.972% 0.925%
iShares Nikkei 225® 0.545% -4.556%
iShares S&P 500 2.367% 0.833%

According to BiotechBee what are the pros and cons of Iovance Biotherapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Lion Biotechnologies Inc diskutieren
Prediction Buy
Perf. (%) 73.39%
Target price 9.000
Change
Ends at 30.11.25

Buy mit Kursziel 9,0